Rid Mousse

NDA 21043, held by Bayer Healthcare LLC. Piperonyl Butoxide; Pyrethrins.

As of Nov 15, 2026, NDA 21043 (Rid Mousse), held by Bayer Healthcare LLC, was first approved by FDA on Mar 7, 2000, with 5 approved supplements and 0 published complete response letters.

First approved: Mar 7, 2000
Review: Standard
Supplements approved: 5
Complete response letters: 0

Approvals and New Uses

The original application and every efficacy supplement, newest first; all 6 submissions below

Date	Submission	Status	Documents
Mar 7, 2000	Original applicationNew dosage form · Standard review	Approved	Review Letter Label

Products

1 strengths and forms

Product	Active ingredient	Marketing
Rid Mousse4%;EQ 0.33% BASE · aerosol;topical	Piperonyl Butoxide; Pyrethrins	Discontinued

All 6 submissions, including labeling and manufacturing supplements


May 26, 2006	Supplement 6Labeling · Standard review	Approved	Letter
Dec 20, 2004	Supplement 5Labeling · Standard review	Approved	Letter
Oct 25, 2002	Supplement 3Manufacturing · Standard review	Approved	None posted
Mar 27, 2001	Supplement 2Manufacturing · Standard review	Approved	None posted
Sep 22, 2000	Supplement 1Manufacturing · Standard review	Approved	None posted
Mar 7, 2000	Original applicationNew dosage form · Standard review	Approved	Review Letter Label

Identifiers

Application: NDA 21043
Drugs@FDA: Overview at FDA
Company: Bayer Healthcare

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters